Vogloyd 3D 1mg/500mg/0.3mg Tablet SR
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Vogloyd 3D 1mg/500mg/0.3mg Tablet SR
TriDiabetol 1mg/500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. TriDiabetol should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintaining regular mealtimes and carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals must consult their doctor. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Vogloyd 3D 1mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vogloyd 3D 1mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing. Consume the Vogloyd 3D 1mg/500mg/0.3mg Extended-Release tablet on an empty stomach.
Common Side effects of Vogloyd 3D 1mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vogloyd 3D 1mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Vogloyd 3D 1mg/500mg/0.3mg Extended-Release Tablet on an empty stomach.
How Vogloyd 3D 1mg/500mg/0.3mg Tablet SR works:
Vogloyd 3D SR tablets (1mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Vogloyd 3D 1mg/500mg/0.3mg Tablet SR ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vogloyd 3D 1mg/500mg/0.3mg SR Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vogloyd 3D 1mg/500mg/0.3mg tablet likely poses a risk during lactation. Available human data indicate potential drug transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Vogloyd 3D 1mg/500mg/0.3mg Tablet SR is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Exercise caution when prescribing Vogloyd 3D 1mg/500mg/0.3mg Tablet SR to individuals with hepatic impairment. Dosage modification of Vogloyd 3D 1mg/500mg/0.3mg Tablet SR may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate Vogloyd 3D 1mg/500mg/0.3mg Tablet SR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.
What if you forget to take Vogloyd 3D 1mg/500mg/0.3mg Tablet SR :
Should you forget a dose of Vogloyd 3D 1mg/500mg/0.3mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogloyd 3D 1mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently